FIIs increase holding in 3 pharma cos: Granules sees 154% quarterly rise

Granules India is the most attractive in this chart with the FIIs have increased their holding to 7.25%, which was 2.85% as on June 30.

Despite their heavy selling in equities in the second quarter ended September 30, the foreign instittutional investors (FIIs) have increased their holding in as many as three pharma companies for the Q2 FY16.

Granules India Ltd is the most attractive in this chart with the FIIs have increased their holding to 7.25%, which was 2.85% as on June 30. This shows a 154.38% jump in FIIs share holding in the company. For the first half of the current fiscal, the FIIs’ share holding in the company has surged by 79.45%. FIIs holding in the company was at 4.04% as on March 31, 2015.

Similarly, Biocon Ltd has witnessed the FII share holding going up by 2.18% to 11.83% on Q-o-Q basis. For the first six months of financial year 2015-16, the FIIs’ share holding in the company has soared by 10.25%. FIIs holding in the company stood at 10.73% as on March 31, 2015.

Despite FIIs reduced their share holding in the second quarter in Cadila Healthcare, on a half yearly basis, the company has seen FIIs increased their stock holding by 4.66% to 6.73% as on Septemeber 30, 2015. For the second quarter, the company saw FIIs holding declined by 5.71%.

For the first half of the current fiscal shares of Granule India and Cadila Healthcare have posted a surge of 65.50% and 20.63% respectively. However, during he review period, Biocon Ltd’s stock has fallen by 5.52%.